美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

10.28

+0.19001.88%

盤後：10.280.00000.00%16:05 EDT

成交量：13.46萬

成交額：135.22萬

市值：3.85億

市盈率：-2.43

高：10.49

開：10.18

低：9.78

收：10.09

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

ORUKA THERAPEUTICS INC

交易所：

NASDAQ

成立時間：

- -

員工人數：

28

公司地址：

855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States

官網：

http://orukatx.com

郵編：

94025

電話：

傳真：

- -

簡介：

Oruka Therapeutics, Inc.公司根據日期為2008年9月24日的協議和合併重組計劃的條款完成了與ARCA Colorado的業務合併（合併），並於2008年10月28日進行了修訂，其中Nuvelo，Inc.的全資子公司與ARCA Colorado合併，ARCA Colorado在合併後繼續作為存續公司和Nuvelo，Inc.的全資子公司。緊隨合併后，該公司從Nuvelo，Inc.更名為ARCA Biopharma，Inc.。Nuvelo最初註冊成立為HYSEQ。該公司是一家臨床階段的生物製藥公司，專註於開發針對銀屑病、炎症和免疫學適應症的新型單克隆抗體療法。

董事

名稱

職位

Michael R. Bristow

President and Chief Executive Officer and Director

Robert E. Conway

Director, Chairman

Anders Hove

Director

Dan J. Mitchell

Director

Jacob Ma Weaver

Director

James Flynn

Director

Linda Grais

Director

Raymond L. Woosley

Director

股東

名稱

職位

Michael R. Bristow

President and Chief Executive Officer and Director

Thomas A. Keuer

Chief Operating Officer

C. Jeffrey Dekker

Chief Financial Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ORKA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":10.28,"timestamp":1745870400000,"preClose":10.09,"halted":0,"volume":134553,"hourTrading":{"tag":"盘后","latestPrice":10.28,"preClose":10.28,"latestTime":"16:05 EDT","volume":2548,"amount":26193.44,"timestamp":1745870709415},"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"盤後交易","change":0.19,"latestTime":"04-28 17:31:16 EDT","open":10.18,"high":10.49,"low":9.78,"amount":1352157.587,"amplitude":0.070367,"askPrice":10.52,"askSize":1,"bidPrice":8.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":10.09,"preHourTrading":{"tag":"盘前","latestPrice":9.93,"preClose":10.09,"latestTime":"04:40 EDT","volume":3,"amount":31.809998999999998,"timestamp":1745829655302},"postHourTrading":{"tag":"盘后","latestPrice":10.28,"preClose":10.28,"latestTime":"16:05 EDT","volume":2548,"amount":26193.44,"timestamp":1745870709415},"volumeRatio":0.597272,"impliedVol":0.8822,"impliedVolPercentile":0.6512},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.597272,"shares":37440510,"dividePrice":0,"high":10.49,"amplitude":0.070367,"preClose":10.09,"low":9.78,"week52Low":5.485,"pbRate":"1.01","week52High":53.88,"institutionHeld":0.0223,"latestPrice":10.28,"committee":0.980198,"eps":-4.225857,"divideRate":0,"volume":134553,"delay":0,"ttmEps":-4.225857,"open":10.18,"prevYearClose":19.39,"prevWeekClose":10.09,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":9.3,"twentyDayClose":12.5,"sixtyDayClose":12.67},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1877171755,"employeeNum":28,"address":"855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States","zipCode":"94025","officePhone":"(650) 606-7910"},"stockCompanyDetail":{"websiteUrl":"http://orukatx.com","stockEarnings":[{"period":"1week","weight":0.0944},{"period":"1month","weight":-0.1141},{"period":"3month","weight":-0.1723},{"period":"6month","weight":-0.6395},{"period":"1year","weight":-0.7584},{"period":"ytd","weight":-0.4796}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Oruka Therapeutics, Inc.公司根據日期為2008年9月24日的協議和合併重組計劃的條款完成了與ARCA Colorado的業務合併（合併），並於2008年10月28日進行了修訂，其中Nuvelo，Inc.的全資子公司與ARCA Colorado合併，ARCA Colorado在合併後繼續作為存續公司和Nuvelo，Inc.的全資子公司。緊隨合併后，該公司從Nuvelo，Inc.更名為ARCA Biopharma，Inc.。Nuvelo最初註冊成立為HYSEQ。該公司是一家臨床階段的生物製藥公司，專註於開發針對銀屑病、炎症和免疫學適應症的新型單克隆抗體療法。","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":0.038367},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.074511},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.027833},{"month":4,"riseRate":0.529412,"avgChangeRate":0.094265},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.014024},{"month":8,"riseRate":0.0625,"avgChangeRate":-0.146138},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.080322},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.053682},{"month":11,"riseRate":0.625,"avgChangeRate":0.003334},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003439}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Robert E. Conway","position":"Director, Chairman"},{"name":"Anders Hove","position":"Director"},{"name":"Dan J. Mitchell","position":"Director"},{"name":"Jacob Ma Weaver","position":"Director"},{"name":"James Flynn","position":"Director"},{"name":"Linda Grais","position":"Director"},{"name":"Raymond L. Woosley","position":"Director"}],"executives":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Thomas A. Keuer","position":"Chief Operating Officer"},{"name":"C. Jeffrey Dekker","position":"Chief Financial Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-25","current":-4.304201,"percent":0.484848,"low":-5.124049,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"high":-2.779284,"avg":-4.125453,"sd":0.690217,"marketCap":393125355},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355}],"updateTime":1745865091817}}}